Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   33    
Direct Shares   1,028,565    

Indirect Shares

   243,774,473      
Direct Value   $73,688,093    

Indirect Value

   $16,499,611,814      
Total Shares   244,803,038      
Total Value   $16,573,299,907      


Incyte Corp $32,169,874 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,197,386 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,254,270 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $284,483 Incyte Corp $32,169,874 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,197,386 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,254,270 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $284,483
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2021-06-22 205,752 2021-06-22 38,452,877    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
* Premium Members only  

Records found :    496         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 14 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
XOMA XOMA Corporation Director   –       •       •   2014-12-18 4 S $4.29 $710,687 I/I (165,700) 424,785 0 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-19 4 B $9.08 $711,115 I/I 78,045 6,274,969 1.5 -
INVA Innoviva Inc officerTitle   –       •      –    2005-12-13 4 S $21.11 $714,362 D/D (33,840) 0 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-15 4 B $8.10 $717,201 I/I 84,670 6,204,630 1.5 -
GHDX Genomic Health Inc Director   –       •      –    2006-12-06 4 B $21.58 $737,532 I/I 34,173 1,231,550 2.1 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-26 4 B $17.89 $750,902 I/I 41,873 407,211 1.5 -
XOMA XOMA Corporation Director   –       •       •   2015-01-02 4 S $3.55 $753,740 I/I (212,100) 388,063 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2011-10-04 4 B $17.48 $796,644 I/I 45,584 9,403,000 1.5 -
XOMA XOMA Corporation Director   –       •       •   2014-12-29 4 S $3.68 $812,440 I/I (221,000) 401,032 0 -
INCY Incyte Corp Director   –       •      –    2007-08-03 4 B $4.83 $814,564 I/I 168,797 1,729,988 2.1 -
GHDX Genomic Health Inc Director   –       •       •   2007-03-01 4 B $17.77 $831,454 I/I 45,929 1,561,935 2.25 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-26 4 B $10.80 $839,524 I/I 77,639 6,502,773 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-21 4 B $12.01 $846,886 I/I 70,173 6,965,853 1.5 -
INCY Incyte Corp Director   –       •      –    2007-11-16 4 B $8.30 $849,221 I/I 102,285 2,761,217 2.1 -
NGNE Neurogene 10% Owner   –       –       •   2016-03-15 4 B $7.88 $877,066 I/I 109,912 6,601,891 1.5 -
NGNE Neurogene Director   –       •       •   2019-08-07 4 B $2.96 $882,884 I/I 289,725 10,105,159 2.25 -
INCY Incyte Corp Director   –       •      –    2007-11-15 4 B $8.62 $934,766 I/I 108,405 2,658,932 2.1 -
INCY Incyte Corp Director   –       •       •   2007-12-19 4 B $10.61 $946,195 I/I 89,198 4,276,686 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2021-08-12 4 B $85.58 $958,954 I/I 10,986 13,058,994 2.25 %
NGNE Neurogene 10% Owner   –       –       •   2016-01-14 4 B $7.91 $959,882 I/I 117,953 6,128,358 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-30 4 B $14.92 $969,966 I/I 65,002 7,515,458 1.5 -
INCY Incyte Corp Director   –       •       •   2007-12-17 4 B $10.60 $1,001,945 I/I 94,565 4,133,664 2.25 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-22 4 B $12.51 $1,011,570 I/I 79,131 7,044,984 1.5 -
INCY Incyte Corp Director   –       •       •   2007-12-10 4 B $9.54 $1,035,184 I/I 108,461 3,714,145 2.25 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-20 4 B $8.90 $1,062,538 I/I 112,034 6,375,941 1.5 -
  496  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14  15   16   17   18   19   20      
  Page 14 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us